Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 290
-2
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    NoAAC Longitudinal Registry of Treatment Outcomes in iSGS

    Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction...

    Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

    We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

    Eradicating Syphilis mediated neonatal deaths in Ghana through active molecular biosurveillance

    Syphilis is a devastating sexally transmitted infection (STI) caused by Treponema pallidum subspecies pallidum...

    Backer Badge Funded